454 related articles for article (PubMed ID: 22169692)
41. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
42. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.
Danilewicz M; Sikorska B; Wagrowska-Danilewicz M
Med Sci Monit; 2003 Mar; 9(3):MT42-7. PubMed ID: 12640351
[TBL] [Abstract][Full Text] [Related]
44. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
45. MMP13 polymorphism decreases risk for dental caries.
Tannure PN; Küchler EC; Falagan-Lotsch P; Amorim LM; Raggio Luiz R; Costa MC; Vieira AR; Granjeiro JM
Caries Res; 2012; 46(4):401-7. PubMed ID: 22710194
[TBL] [Abstract][Full Text] [Related]
46. Matrix metalloproteinase-2 promoter variability in psoriasis.
Vasku V; Bienertova Vasku J; Slonková V; Kanková K; Vasku A
Arch Dermatol Res; 2009 Jul; 301(6):467-73. PubMed ID: 19360430
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
[TBL] [Abstract][Full Text] [Related]
48. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease.
Kang HS; Kim SK; Cho BK; Kim YY; Hwang YS; Wang KC
Neurosurgery; 2006 Jun; 58(6):1074-80; discussion 1074-80. PubMed ID: 16723886
[TBL] [Abstract][Full Text] [Related]
49. [Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer].
Li K; Xu HM; Chen JQ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2113-6. PubMed ID: 16313820
[TBL] [Abstract][Full Text] [Related]
50. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
[TBL] [Abstract][Full Text] [Related]
51. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
52. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.
Ortak H; Demir S; Ateş O; Söğüt E; Alim S; Benli I
Exp Eye Res; 2013 Aug; 113():151-5. PubMed ID: 23791966
[TBL] [Abstract][Full Text] [Related]
53. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
54. Polymorphism of THBS1 rs1478604 A>G in 5-untranslated region is associated with lymph node metastasis of gastric cancer in a Southeast Chinese population.
Lin XD; Chen SQ; Qi YL; Zhu JW; Tang Y; Lin JY
DNA Cell Biol; 2012 Apr; 31(4):511-9. PubMed ID: 22011138
[TBL] [Abstract][Full Text] [Related]
55. Polymorphisms of MMP9 and TIMP2 in Patients with Varicose Veins.
Kunt AT; Isbir S; Gormus U; Kahraman OT; Arsan S; Yilmaz SG; Isbir T
In Vivo; 2015; 29(4):461-5. PubMed ID: 26130791
[TBL] [Abstract][Full Text] [Related]
56. Genetic polymorphisms in Matrix Metalloproteinases -1 and -7 and susceptibility to gastric cancer: an association study and meta-analysis.
Fang WL; Liang WB; Gao LB; Zhou B; Xiao FL; Zhang L
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):203-10. PubMed ID: 23893803
[TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
58. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
[TBL] [Abstract][Full Text] [Related]
59. Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk.
Zhang MW; Jin MJ; Yu YX; Zhang SC; Liu B; Jiang X; Pan YF; Li QI; Ma SY; Chen K
Mol Carcinog; 2012 Oct; 51 Suppl 1():E21-31. PubMed ID: 21976437
[TBL] [Abstract][Full Text] [Related]
60. [Interleukin-10-1082 promoter polymorphism and the risk of gastric cancer].
Yin YQ; Liu CJ; Zhang MM; Zhou Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):378-81. PubMed ID: 22812241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
